Evidence map›Paper›PMID 37408563›Full record

ArticleFrontiers in chemistry2023

Chemical profiling of Sanjin tablets and exploration of their effective substances and mechanism in the treatment of urinary tract infections.

Meng-Yuan Li, Yang Li, Li-Li Wang, Feng Xu, Xu-Yan Guo, Jing Zhang, Yang Lv, Peng-Pu Wang, Shun-Qi Wang, Jian-Guo Min and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Meng-Yuan LiSchool of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China.
Yang LiSchool of Pharmaceutical Sciences, Peking University, Beijing, China.
Li-Li WangSchool of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China.
Feng XuSchool of Pharmaceutical Sciences, Peking University, Beijing, China.
Xu-Yan GuoSchool of Pharmaceutical Sciences, Peking University, Beijing, China.
Jing ZhangSchool of Pharmaceutical Sciences, Peking University, Beijing, China.
Yang LvSchool of Pharmaceutical Sciences, Peking University, Beijing, China.
Peng-Pu WangSchool of Pharmaceutical Sciences, Peking University, Beijing, China.
Shun-Qi WangSchool of Pharmaceutical Sciences, Peking University, Beijing, China.
Jian-Guo MinGuilin Sanjin Pharmaceutical Company Limited, Guilin, China.
Xun ZouGuilin Sanjin Pharmaceutical Company Limited, Guilin, China.
Shao-Qing CaiSchool of Pharmaceutical Sciences, Peking University, Beijing, China.
Peking University · CNFirst Affiliated Hospital of Henan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chemical profilingLC-MSnmolecular dockingnetwork pharmacologySanjin tabletsurinary tract infections

Identifiers

PMID37408563
PMCPMC10318440
OpenAlexW4381334845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.